STERIS plc (STE)
Official siteHEALTHCARE • MEDICAL DEVICES • NYSE
Market Cap: $25.67B
Last updated: Nov 17, 2026 at 11:06 AM ET
STERIS plc (STE) Stock Forecast
Analysts expect STERIS (STE) to earn $11.41 per share in the fiscal year ending Mar 31, 2027, on revenue of $6.37B. Of 8 analysts, 5 rate the stock Buy or Strong Buy, 3 Hold and 0 Sell or Strong Sell, for a consensus of Buy. For the fiscal year ending Mar 31, 2028, the EPS consensus is $12.38.
Analyst Ratings
Scoring Strong Buy as 1 and Strong Sell as 5, the 8 ratings average 2.25, inside the Buy band from 1.5 up to 2.5. Buy and Strong Buy make up 63% of the ratings.
| Rating | Analysts | Share |
|---|---|---|
| Strong Buy | 1 | 12.5% |
| Buy | 4 | 50.0% |
| Hold | 3 | 37.5% |
| Sell | 0 | 0.0% |
| Strong Sell | 0 | 0.0% |
- Consensus
- Buy
- Total analysts
- 8
Price Target
Analyst price targets are part of paid GNG plans. See plans
Annual Estimates
From the first fiscal year below to the second, the EPS consensus rises 8.5% and revenue estimates rise 6.6%.
- Fiscal year ending Mar 31, 2027
- $11.41
- EPS consensus, revenue $6.37B
- Fiscal year ending Mar 31, 2028
- $12.38
- EPS consensus, revenue $6.79B
- Next report
- Feb 2, 2027
- Estimated
EPS range
Revenue range
| Fiscal year ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Mar 31, 2027 | $11.41 | $11.19 to $11.47 | 8 | $6.37B | $6.36B to $6.39B | 8 |
| Mar 31, 2028 | $12.38 | $12.04 to $12.58 | 8 | $6.79B | $6.68B to $6.96B | 8 |
Quarterly Estimates
The EPS consensus rises from $2.80 for the quarter ending Dec 31, 2026 to $3.18 for the quarter ending Mar 31, 2027.
EPS range
Revenue range
| Quarter ending | EPS consensus | EPS range | EPS analysts | Revenue consensus | Revenue range | Rev. analysts |
|---|---|---|---|---|---|---|
| Dec 31, 2026 | $2.80 | $2.78 to $2.83 | 7 | $1.60B | $1.59B to $1.61B | 7 |
| Mar 31, 2027 | $3.18 | $3.07 to $3.34 | 9 | $1.71B | $1.57B to $1.84B | 9 |
Estimate Revisions
| Period | Up 30 days | Down 30 days |
|---|---|---|
| Fiscal year ending Mar 31, 2028 | 1 | 0 |
EPS Trend
Over the last 90 days, the EPS consensus for the fiscal year ending Mar 31, 2027 has risen 2.2% from $11.16.
| Period | Now | 7 days ago | 30 days ago | 60 days ago | 90 days ago | Change |
|---|---|---|---|---|---|---|
| Fiscal year ending Mar 31, 2027 | $11.41 | $11.20 | $11.17 | $11.17 | $11.16 | +2.3% |
| Fiscal year ending Mar 31, 2028 | $12.38 | $12.33 | $12.25 | $12.25 | $12.24 | +1.2% |
| Quarter ending Dec 31, 2026 | $2.80 | $2.80 | $2.81 | $2.81 | $2.81 | -0.4% |
Frequently Asked Questions About STE
What is the STE stock forecast?
Consensus analyst estimates put STERIS's EPS at $11.41 for the fiscal year ending Mar 31, 2027, on revenue of $6.37B. The consensus rating from 8 analysts is Buy.
How do analysts rate STE stock?
Of 8 analysts covering STERIS, 1 rates it Strong Buy, 4 Buy, 3 Hold, 0 Sell and 0 Strong Sell, for a consensus of Buy.
What EPS do analysts expect from STE next year?
For the fiscal year ending Mar 31, 2027, the consensus EPS estimate is $11.41, with estimates from $11.19 to $11.47 from 8 analysts. For the fiscal year ending Mar 31, 2028, the consensus EPS estimate is $12.38, with estimates from $12.04 to $12.58 from 8 analysts.
What revenue do analysts expect from STERIS next year?
For the fiscal year ending Mar 31, 2027, the consensus revenue estimate is $6.37B, with estimates from $6.36B to $6.39B. For the fiscal year ending Mar 31, 2028, the consensus revenue estimate is $6.79B, with estimates from $6.68B to $6.96B.
How many analysts cover STE?
8 analysts rate STERIS stock, and 8 analysts estimate its EPS for the fiscal year ending Mar 31, 2027.
STE pages: Overview, Dividends, Earnings, Forecast, Financials, Valuation, Competitors, Government Contracts